MAZE vs. WLDN
MAZE (Maze Therapeutics, Inc) and WLDN (Willdan Group, Inc.) are both stocks. MAZE operates in Biotechnology (Healthcare), while WLDN operates in Engineering & Construction (Industrials). Over the past year, MAZE returned 79.48% vs 72.52% for WLDN. At a 0.12 correlation, their price movements are largely independent.
Performance
MAZE vs. WLDN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MAZE achieves a -41.95% return, which is significantly lower than WLDN's -7.10% return.
MAZE
- 1D
- -0.17%
- 1M
- -9.00%
- YTD
- -41.95%
- 6M
- -38.11%
- 1Y
- 79.48%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
WLDN
- 1D
- -1.21%
- 1M
- 5.06%
- YTD
- -7.10%
- 6M
- -6.97%
- 1Y
- 72.52%
- 3Y*
- 71.89%
- 5Y*
- 19.75%
- 10Y*
- 24.56%
MAZE vs. WLDN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
MAZE Maze Therapeutics, Inc | -41.95% | 157.01% |
WLDN Willdan Group, Inc. | -7.10% | 184.78% |
Correlation
The correlation between MAZE and WLDN is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jan 31, 2025 | 0.12 |
Fundamentals
MAZE:
$1.30B
WLDN:
$1.48B
MAZE:
-$2.63
WLDN:
$3.71
MAZE:
3.79
WLDN:
4.78
MAZE:
$0.00
WLDN:
$684.28M
MAZE:
-$1.15M
WLDN:
$261.18M
MAZE:
-$126.66M
WLDN:
$64.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MAZE vs. WLDN — Risk / Return Rank
MAZE
WLDN
MAZE vs. WLDN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Maze Therapeutics, Inc (MAZE) and Willdan Group, Inc. (WLDN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MAZE | WLDN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.22 | ||
| Sortino ratioReturn per unit of downside risk | +0.15 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.26 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.43 | 1.41 | +0.02 |
| Martin ratioReturn relative to average drawdown | 3.16 | 2.99 | +0.17 |
Loading charts...
Drawdowns
MAZE vs. WLDN - Drawdown Comparison
The maximum MAZE drawdown since its inception was -54.51%, smaller than the maximum WLDN drawdown of -89.19%. Use the drawdown chart below to compare losses from any high point for MAZE and WLDN.
Loading charts...
Drawdown Indicators
| MAZE | WLDN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.51% | -89.19% | +34.68% |
Max Drawdown (1Y)Largest decline over 1 year | -54.51% | -50.41% | -4.10% |
Max Drawdown (3Y)Largest decline over 3 years | — | -50.41% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -72.59% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -78.71% | — |
Current DrawdownCurrent decline from peak | -53.60% | -28.63% | -24.97% |
Average DrawdownAverage peak-to-trough decline | -20.99% | -42.35% | +21.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.60% | 23.78% | +0.82% |
Volatility
MAZE vs. WLDN - Volatility Comparison
Maze Therapeutics, Inc (MAZE) has a higher volatility of 11.72% compared to Willdan Group, Inc. (WLDN) at 8.81%. This indicates that MAZE's price experiences larger fluctuations and is considered to be riskier than WLDN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MAZE | WLDN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.72% | 8.81% | +2.91% |
Volatility (6M)Calculated over the trailing 6-month period | 56.26% | 50.77% | +5.49% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.54% | 65.10% | +24.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 94.20% | 55.91% | +38.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 94.20% | 54.13% | +40.07% |
Dividends
MAZE vs. WLDN - Dividend Comparison
Neither MAZE nor WLDN has paid dividends to shareholders.
Financials
MAZE vs. WLDN - Financials Comparison
This section allows you to compare key financial metrics between Maze Therapeutics, Inc and Willdan Group, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MAZE and WLDN have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MAZE has higher volatility (11.72%) compared to WLDN (8.81%). In terms of maximum drawdown, MAZE dropped -54.51% vs WLDN's -89.19%.
WLDN currently has the higher Sharpe Ratio (1.09 vs 0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MAZE and WLDN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer